Your recent Intel thread got me thinking about Markel.
One of my dumbest screening criteria:
The difference between 5-year EPS growth and 5-year total return. The “hiding in plain sight” list: getting cheaper and cheaper.
Switch Book value per share for EPS and you get:
We generally use five-year periods to measure our performance. Over the five-year period ended December 31, 2021, the compound annual growth in book value per common share outstanding was 11%. Over the five-year period ended December 31, 2021, our share price increased at a compound annual rate of 6%
In the earnings call Tom Gayner sounded very bullish about share repurchase and looking for ways to increase it, while still staying disciplined. Seems like a good value at 1.22 times BPS. Its long run average is closer to 1.5.
And unlike Intel, its business is doing very well with the exception of P&C retrocessional reinsurance, which they have already scaled back on.